COVID-19 updates, including vaccine information, for our patients and visitors Learn More

Menu
Search

Roger Tsien Receives Neurosciences Prize

 

September 21, 2005  |  

The University of North Carolina (UNC) at Chapel Hill has named Roger Tsien, Ph.D., University of California, San Diego (UCSD) professor of pharmacology, chemistry and biochemistry, the recipient of the fifth annual Perl-UNC Neuroscience Prize.

The prize carries a $10,000 award and is given to recognize a seminal achievement in neuroscience. Tsien was recognized for developing molecular indicators that have revolutionized the optical monitoring of neurons. He has developed a wide variety of tools for optically monitoring the structure and function of cells and molecules in the nervous system, including calcium indicator dyes, genetically coded protein biosensors and modifications to green fluorescent protein, GFP. These tools have made it possible for scientists to visualize signaling processes in nerve cells both in cell culture and in the brains of living animals.

Tsien, a Howard Hughes Medical Institute investigator, is a member of the Institute of Medicine, which advises the nation on improving health, and the National Academy of Sciences. His laboratory's goal is to gain a better understanding of signaling inside individual living cells, in neuronal networks and in tumors,. His team designs, synthesizes and uses new molecules that detect or manipulate biochemical signals.

Previous recipients of the prize are Dr. David Julius of the University of California at San Francisco; Dr. Roderick MacKinnon of Rockefeller University; co-recipients Dr. Linda Buck of the Fred Hutchinson Cancer Research Center in Seattle and Dr. Richard Axel of Columbia University; and, last years recipient, Dr. Yves Barde of the Biocenter at the University of Basel in Switzerland.

News Media Contact:

Sue Pondrom, 619-543-6163, spondrom@ucsd.edu




Media Contact

Share This Article


Related News

1/20/2021
UC San Diego study supports launch of Phase I clinical trial to test a designer DNA agent — an antisense oligonucleotide that targets a gene called IRF4 — in patients with multiple myeloma.
1/12/2021
Researchers at UC San Diego School of Medicine, in collaboration with Dutch scientists, have found that certain metabolites — small molecules produced by the process of metabolism — may be predictive ...
1/10/2021
University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Sciences researchers report that starting tobacco products, including e-cigarettes, before the age of 18 ...
1/7/2021
Chemicals used for vaping break down zipper-like junctions between cells in the gut, leading to chronic inflammation and potential for other health concerns.



Follow Us